Dr Dietrich - MPR

Dr Dietrich

COMPLETE CASE
 

Biomarker Testing in Advanced NSCLC: A Community Oncology Perspective

Martin Dietrich, MD, PhD
Medical Oncologist,
Florida Hospital Cancer Institute,
Orlando, Florida

Dr. Dietrich reviews FDA-approved and emerging biomarkers in NSCLC, and discusses the importance of a multidisciplinary approach and proper biopsy technique in facilitating a successful and timely molecular characterization of NSCLC

 

CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC

Case Study
Patient Case: Biomarker Testing in Advanced NSCLC


Chung-Che (Jeff) Chang, MD, PhD
A Case-Based Pathology Perspective on Biomarker Testing in NSCLC


Gaetane C. Michaud, MD
A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC


Mark A. Socinski, MD
A Case-Based Oncology Perspective on Biomarker Testing in NSCLC

 

EXPERTS’ INSIGHTS ON BIOMARKER TESTING
IN ADVANCED NSCLC

Chung-Chee (Jeff) Chang, MD, PhD
A Pathology Perspective on Biomarker Testing in NSCLC


Martin Dietrich, MD, PhD
A Community Oncology Perspective on Biomarker Testing in NSCLC


Gaetane C. Michaud, MD
A Pulmonology Perspective on Biomarker Testing in NSCLC


Mark A. Socinski, MD
An Oncology Perspective on Biomarker Testing in NSCLC

Webcasts